Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ChemScreener: an active learning enabled hit discovery workflow with WDR5 inhibitor case study.

Journal of cheminformatics·2026
Same author

Extrinsic lipids are absorbed and accumulate in colorectal cancer.

Gut·2026
Same author

Sex-specific response of the human plasma lipidome to short-term cold exposure.

Biochimica et biophysica acta. Molecular and cell biology of lipids·2024
Same author

Mitochondrial lipidomes are tissue specific - low cholesterol contents relate to UCP1 activity.

Life science alliance·2024
Same author

Validation of the predictive value of BDNF -87 methylation for antidepressant treatment success in severely depressed patients-a randomized rater-blinded trial.

Trials·2024
Same author

Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles.

ACS chemical biology·2024

Related Experiment Video

Updated: Jun 20, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Chemogenomic analysis of safety profiling data.

Josef Scheiber1, Jeremy L Jenkins

  • 1Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.

Methods in Molecular Biology (Clifton, N.J.)
|September 4, 2009
PubMed
Summary

This study introduces computational methods to analyze preclinical safety profiling data. These analyses help optimize drug discovery panels and understand compound liabilities for safer drug development.

Area of Science:

  • Drug discovery and development
  • Computational chemistry
  • Toxicology

Background:

  • Early drug discovery relies on preclinical safety profiling to identify compound liabilities.
  • Large-scale screening generates vast amounts of binding data against numerous targets.
  • Analyzing this data is crucial for optimizing safety assessment strategies.

Purpose of the Study:

  • To introduce computational methods for analyzing preclinical safety profiling data.
  • To enable understanding of compound and target promiscuity.
  • To facilitate optimization of safety profiling panels and toxicity assessments.

Main Methods:

  • Computational analysis of large-scale compound-target binding data.
  • Protocols for assessing compound promiscuity at the chemical structure level.

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Related Experiment Videos

Last Updated: Jun 20, 2026

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

  • Methods for evaluating target promiscuity and global chemical similarity.
  • Techniques for elucidating hidden patterns in safety profiling datasets.

    • Main Results:

    • Developed computational protocols to analyze compound and target promiscuity.
    • Enabled rapid assessment of chemical similarity between compounds and targets.
    • Demonstrated utility in optimizing target panel composition and understanding toxicities.
    • Provided a method for uncovering hidden patterns within safety profiling data.

    Conclusions:

    • Computational analysis of safety profiling data is essential for efficient drug discovery.
    • These methods enhance the understanding of compound liabilities and target characteristics.
    • Optimized safety profiling panels lead to improved prediction of potential toxicities.
    • Uncovering hidden patterns can reveal novel insights into drug safety.